Registry for stroke and transient ischemic attack patients
STROKE-CARD REGISTRY: Extension of Standard Care in Patients With Ischemic Stroke and Transient Ischemic Attack
This study is trying to see how well post-stroke care works for people who have had a stroke or a mini-stroke, and how it affects their recovery and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | VASCage GmbH Academic / other |
| Locations | 2 sites (Vienna, State of Vienna and 1 other locations) |
| Trial ID | NCT04582825 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the quality of post-stroke care and its impact on patients who have experienced ischemic stroke or transient ischemic attack (TIA). It involves a multicenter cohort and the establishment of a biobank for future research. The study will document the outcomes of a previously implemented disease-management program called STROKE-CARD care, which has shown promise in reducing cardiovascular risk and improving quality of life. The goal is to gather extensive data to better understand long-term effects and improve post-stroke care.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have recently experienced an acute ischemic stroke or high-risk TIA.
Not a fit: Patients living outside the catchment area of the participating centers or those under law enforcement or military service may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients recovering from stroke or TIA.
How similar studies have performed: Other studies have shown success with similar approaches in improving post-stroke care and outcomes, indicating that this methodology is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with acute ischemic stroke or high-risk TIA (ABCD2-Score ≥ 4 points) treated at the Department of Neurology of each study center within 30 days after onset * Age ≥ 18 years * Written informed consent Exclusion Criteria: * Patients living outside the catchment area of the participating centers * Patients under law enforcement or within mandatory military service * Age \< 18 years
Where this trial is running
Vienna, State of Vienna and 1 other locations
- Hospital St. John of God — Vienna, State of Vienna, Austria (Recruiting)
- Medical University Innsbruck — Innsbruck, Tyrol, Austria (Recruiting)
Study contacts
- Principal investigator: Stefan Kiechl, MD — Medical University Innsbruck
- Study coordinator: Christian Böhme, MD
- Email: christian.boehme@i-med.ac.at
- Phone: +43 512 504
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.